Abstract: Provided are tissue webs and products that have a modest degree of surface texture, but are still soft. In certain instances the tissue products and webs may also have good sheet bulk and low stiffness. For example, the tissue products may have good softness, such as a TS7 value (measured using the EMTEC Tissue Softness Analyzer) less than 11.0, and a textured surface, such as an R2 value from about 11,000 to about 20,000 (measured using an OpTiSurf tester). The foregoing tissue products may have a sheet bulk greater than about 8.0 cc/g and a Stiffness Index less than about 15.0. In certain instances the tissue product and webs may be through-air dried and may be either creped or uncreped.

Abstract: Provided are tissue products containing an additive adapted to reduce skin irritation, such as a lotion, and a colorant may be manufactured with relatively low total add-on amounts of the additive without reducing effectiveness, while providing the product with a distinct aesthetic appearance. In a specific embodiment, the additive composition comprises an oil, a wax, and a colorant comprising a pigment and a wetting agent. The additive and colorant, which are preferably both hydrophobic and non-aqueous, are be added simultaneously and in the same pattern so as to provide a tissue product having a distinct aesthetic appearance that also provides a cue to the user that the product comprises a soothing additive. In certain instances an aesthetic pattern, particularly a coloured pattern, provides a visual cue to the user and reinforces the benefits of the product, enabling lower additive add-on levels without degrading the user experience.

Abstract: Provided are tissue webs and products that have a modest degree of surface texture, but are still soft. In certain instances the tissue products and webs may also have good sheet bulk and low stiffness. For example, the tissue products may have good softness, such as a TS7 value (measured using the EMTEC Tissue Softness Analyzer) less than 11.0, and a textured surface, such as an R2 value from about 11,000 to about 20,000 (measured using an OpTiSurf tester). The foregoing tissue products may have a sheet bulk greater than about 8.0 cc/g and a Stiffness Index less than about 15.0. In certain instances the tissue product and webs may be through-air dried and may be either creped or uncreped.

Abstract: Low slough, high basis weight tissue webs and products are provided. The tissue webs generally have basis weights greater than about 16 grams per square meter (gsm), while maintaining less than about 4 mg of slough. All while yielding tissue products that are both thick and soft.

Abstract: Low slough, high basis weight tissue webs and products are provided. The tissue webs generally have basis weights greater than about 16 grams per square meter (gsm), while maintaining less than about 4 mg of slough. All while yielding tissue products that are both thick and soft.

Abstract: In general, the present disclosure is directed to creped tissue webs, and products produced therefrom. The creped webs and products are strong, soft, and have fine crepe structure, such as less than about 12, measured as % COV at a STFI wavelength of 16 to 32 mm, using the test method set forth herein. Fine crepe structure is achieved even at basis weights in excess of 16 gsm per ply.

Abstract: In general, the present disclosure is directed to creped tissue webs, and products produced therefrom. The creped webs and products are strong, soft, and have fine crepe structure, such as less than about 12, measured as % COV at a STFI wavelength of 16 to 32 mm, using the test method set forth herein. Fine crepe structure is achieved even at basis weights in excess of 16 gsm per ply.

Abstract: In general, the present disclosure is directed to creped tissue webs, and products produced therefrom. The creped webs and products are strong, soft, and have fine crepe structure, such as less than about 12, measured as % COV at a STFI wavelength of 16 to 32 mm, using the test method set forth herein. Fine crepe structure is achieved even at basis weights in excess of 16 gsm per ply.

Abstract: In general, the present disclosure is directed to creped tissue webs, and products produced therefrom. The creped webs and products are strong, soft, and have improved strike-through and absorbency properties. The improvement in both strike-through and absorbency is achieved in-part by increasing the basis weight of the web, while at the same time reducing the creping composition add-on levels.

Abstract: The present disclosure provides a multi-ply tissue product, also referred to herein as a tissue laminate, wherein the plies are adhesively adjoined by the zoned application of an adhesive. The zoned application of adhesive results in plies being adhesively joined by two or more longitudinally oriented strips of adhesive adjacent to the lateral edges of the ply. The resulting adhesively joined tissue has relatively high degrees of ply attachment, yet has relatively low stiffness.

Abstract: In general, the present disclosure is directed to creped tissue webs, and products produced therefrom. The creped webs and products are strong, soft, and have fine crepe structure, such as less than about 12, measured as % COV at a STFI wavelength of 16 to 32 mm, using the test method set forth herein. Fine crepe structure is achieved even at basis weights in excess of 16 gsm per ply.

Abstract: Low slough, high basis weight tissue webs and products are provided. The tissue webs generally have basis weights greater than about 16 grams per square meter (gsm), while maintaining less than about 4 mg of slough. All while yielding tissue products that are both thick and soft.

Abstract: In general, the present disclosure is directed to creped tissue webs, and products produced therefrom. The creped webs and products are strong, soft, and have improved strike-through and absorbency properties. The improvement in both strike-through and absorbency is achieved in-part by increasing the basis weight of the web, while at the same time reducing the creping composition add-on levels.

Abstract: Tissues having a high level of softness and hand protection in combination with improved cleaning are disclosed. The tissues have been shown to remove more mucus than commercially available tissues.

Abstract: The present invention relates to a method of sequestering skin irritants with a skin irritant sequestering composition comprising a substrate, a hydrophilic skin irritant sequestering agent and a hydrophobic skin irritant sequestering agent. In one embodiment the sequestering agents are comprised of modified and non-modified clays. The present invention further also provides a method of sequestering skin irritants comprising administering to the stratum corneum of an individual's skin a skin irritant sequestering composition comprising a substrate, a skin irritant sequestering amount of a combination of hydrophilic and hydrophobic skin irritant sequestering agents. In one embodiment the skin irritants are bound to sequestering agents present on a substrate. In another embodiment the skin irritants are bound to sequestering agents present on the skin.

Abstract: Facial tissue is provided comprising a tissue substrate, a hydrophilic nasal secretion skin irritant sequestering agent and a hydrophobic nasal secretion skin irritant sequestering agent. In one embodiment the sequestering agents are comprised of modified and non-modified clays. In one embodiment the skin irritants are bound to sequestering agents present on a substrate. In another embodiment the skin irritants are bound to sequestering agents present on the skin.

Abstract: The present invention provides a method of sequestering nasal secretion skin irritants comprising administering to the stratum corneum of an individual's skin a facial tissue comprising a tissue substrate, a nasal secretion skin irritant sequestering amount of a combination of hydrophilic and hydrophobic nasal secretion skin irritant sequestering agents. In one embodiment the sequestering agents are comprised of modified and non-modified clays. In one embodiment the skin irritants are bound to sequestering agents present on a substrate. In another embodiment the skin irritants are bound to sequestering agents present on the skin.

Abstract: The present invention relates to a skin irritant sequestering composition comprising a tissue substrate, a hydrophilic skin irritant sequestering agent and a hydrophobic skin irritant sequestering agent. In one embodiment the sequestering agents are comprised of modified and non-modified clays. In one embodiment, the skin irritants are bound to sequestering agents present on a substrate. In another embodiment the skin irritants are bound to sequestering agents present on the skin.

Abstract: The invention relates to tissue products having improved softness properties and methods of making them. Specifically, improved softness is achieved by incorporating one or more softeners/debonders into the fiber furnish at the wet end of the tissue machine prior to formation, followed by a topical treatment with one or more softeners/debonders after the tissue web is dried. The result is a tissue product with added bulk and a smooth surface feel, both properties contributing to improved softness characteristics.

Abstract: The invention relates to tissue products having improved softness properties and methods of making them. Specifically, improved softness is achieved by incorporating a cationic amidoamine into the fiber furnish at the wet end of the tissue machine prior to formation and/or by topical addition to the tissue web. One or more softeners/debonders can be added to the furnish and/or topically applied to the tissue web after the tissue web is dried. The result is a tissue product with added bulk and a smooth surface feel, both properties contributing to improved softness characteristics.